Navigation Links
KGI 2008 Commencement Features First PhD Graduate, Biotech Painting
Date:5/12/2008

CLAREMONT, Calif., May 12 /PRNewswire/ -- Keck Graduate Institute (KGI) today announced that the May 17, 2008, commencement ceremony will feature the graduation of KGI's first PhD in Applied Life Sciences student, Eric Tan, and the unveiling of KGI's first donated artwork.

"We are very excited and proud of Eric's achievement in becoming the first graduate of our new PhD program," said T. Gregory Dewey, KGI's senior vice president for academic affairs, dean of faculty and Robert E. Finnigan professor. "Eric's academic dedication and original research reflects the kind of performance KGI expects from all of its doctoral students in the PhD program in Applied Life Sciences."

Tan graduated from KGI in 2004 with a Master of Bioscience degree. He then enrolled as the first student in the newly-established PhD program in Applied Life Sciences. For Tan's dissertation on "Isothermal DNA Amplification and Visual Detection for Point of Care Nucleic Acid Detection," he conducted research that contributed to an ongoing project by KGI faculty to develop a hand-held medical device for rapid detection of human pathogens.

During the commencement ceremony, a specially-designed painting by artist Klari Reis will be unveiled. Reis, a San Francisco Bay Area artist specializing in biotech art, donated the painting, Lexapro, as part of the KGI Class of 2008's legacy gift to the school.

Like Reis' other work, Lexapro is a mixed media painting based on magnified, electron microscope images of biological forms found in modern prescription drugs. Lexapro(TM) is a medication developed by Forest Laboratories and Lundbeck designed to treat depression and anxiety.

KGI BACKGROUND

Educating the future leaders of the bioscience industry, Keck Graduate Institute (KGI) offers an interdisciplinary graduate education through its Master of Bioscience (MBS) degree program and its PhD program in Applied Life Sciences. Using team-based learning and real-world
'/>"/>

SOURCE Keck Graduate Institute
Copyright©2008 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2

Related medicine news :

1. Weill Cornell Medical College Announces First Commencement of Its New Medical School Graduates in Doha, Qatar, May 8, 2008
2. Methodist Healthcare - Memphis Hospitals Announces the Commencement of the Tender Offer for Certain Designated Maturities of:
3. Roche Confirms Commencement of Due Diligence with Ventana
4. Broadband Wireless International Corporation Announces the Commencement of Good Faith Talks with HealthPitch
5. Kohn, Swift & Graf, P.C. Announces Commencement of Lawsuit Against Pall Corporation-PLL
6. AIDS.gov Goes 2.0: Government HIV/AIDS Website Now Features a Blog, Podcasts, and More
7. Symposium at Angioplasty Summit TCT Asia Pacific 2008 Features OrbusNeichs Genous(TM) Bio-engineered R stent(TM)
8. AHRQ Web Resource Features 100 Examples of Health Care Innovations and Tools
9. Allegro Diagnostics Announces Publication in Cancer Prevention Research of Prediction Model for Lung Cancer Diagnosis Integrating Clinical and Genomic Features
10. Lupus Webchat April 9 Features Ask the Doctor Open Forum
11. USA TODAY Weight-Loss Challenge Returns For 5th Year With Eight Weeks of Compelling Stories and Online Features
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2008)... Nov. 21 The Providence ...nced that Craig A. Norris, the Company,s,Chief Op...,s Board of,Directors. Mr. Norris, appointment f...on of Steven I. Geringer and returns the board to ...mmittee of the Board. , Mr. Norris, age 41,...
(Date:11/21/2008)...one day lead to a novel technique to combat cancer...althDay News) -- Belgian researchers have discover...of sugar for food, and this might lead to new trea...urvive and proliferate, all cells in the body need...[glucose], a process that requires oxygen. Compare...
(Date:11/21/2008)...ders Intend To Vigorously Protect Investment And R...v. 21 Dr. Stephen Joffe...dment to their Schedule 13D with the U.S. Securiti...filed a 13D disclosing ownership of 11.4% of LCA-V...asikPlus fixed-site laser vision correction center...
(Date:11/21/2008)..., Nov. 21 Barr Pharmaceu...ts shareholders overwhelmingly approved the propos...of Barr by Teva Pharmaceuticals Industries Ltd. (N...rated the overwhelming support of the transaction ...arr,s Chairman and CEO. "We are pleased with the p...
Breaking Medicine News(10 mins):Health News:Craig A. Norris Appointed to Providence Service Corporation Board of Directors 2Health News:Craig A. Norris Appointed to Providence Service Corporation Board of Directors 3Health News:New Approach Keeps Tumor Cells From Refueling 2Health News:Founders & Former Executive Management Team of LCA-Vision Seek Change to Rescue Company 2Health News:Founders & Former Executive Management Team of LCA-Vision Seek Change to Rescue Company 3Health News:Founders & Former Executive Management Team of LCA-Vision Seek Change to Rescue Company 4Health News:Founders & Former Executive Management Team of LCA-Vision Seek Change to Rescue Company 5Health News:Founders & Former Executive Management Team of LCA-Vision Seek Change to Rescue Company 6Health News:Founders & Former Executive Management Team of LCA-Vision Seek Change to Rescue Company 7Health News:Barr Shareholders Approve Pending Teva Acquisition 2Health News:Barr Shareholders Approve Pending Teva Acquisition 3Health News:Barr Shareholders Approve Pending Teva Acquisition 4
...deo, designed to increase emotional well-being and...creased knowledge but did not change behavior or e...y succeeded in increasing patients' knowledge of m...ty of adaptive devices and techniques, it did not ...
...tion to treat kleptomania has failed to find any c...stealing disorder,// according to researchers at t... results leave open the possibility that some medi..., may still be an effective treatment for certain ...
...hat as many as 25 percent of all patients admitted...monia, which can be fatal. // Ventilator-associate...ospital, and studies have shown that this infectio...and double the length of stay of the patient in th...
... Wisconsin is running a pioneering trial of using ...sults of which have //been "encouraging". Amish R... his team of cardiologists began their trial on Ma...cells for cardiac disease) works, it could revolut...
Other Medicine News:Health News:Educational Video Increases Knowledge but Not Behavior 2Health News:Educational Video Increases Knowledge but Not Behavior 3Health News:Study Finds No Conclusive Benefit from Treating Kleptomania 2Health News:Patients Own Dental Plaque may Cause Ventilator-associated Pneumonia 2
(Date:11/20/2008)...Calif., Nov. 20 Bionovo,...l present results from the Phase 1B,clinical tria...atic breast,cancer, BZL101, at the Society for In...ce in Atlanta, Georgia. The Company,s oral presen... will be presented as a part of the Best of the,S...
(Date:11/20/2008)...ass., Nov. 20 Radius Health ("Radi...nal $15 million to its second institutional financ... $82.5 million and the total amount raised since t...ting institutional investors participated in the f... including MPM Capital, The Wellcome Trust, Health...
(Date:11/20/2008)... 20 PAREXEL Internationa...biopharmaceutical services provider, today announc...rovide regulatory consulting and clinical research...e, PAREXEL now has locations throughout five impor...hich also include Argentina, Brazil, Chile, and Me...
(Date:11/19/2008)...O, Nov. 19 Posit Science Corporati...the Society for Neuroscience,Annual Conference in...e,training may benefit Baby Boomers. The compute...m (TM) uses adaptive exercises that target auditor...ed to drive generalized,improvements in cognition...
Breaking Medicine Technology:Bionovo Presents Positive Results from Phase 1B Trial of BZL101 for Metastatic Breast Cancer at the Society for Integrative Oncology 2Bionovo Presents Positive Results from Phase 1B Trial of BZL101 for Metastatic Breast Cancer at the Society for Integrative Oncology 3Bionovo Presents Positive Results from Phase 1B Trial of BZL101 for Metastatic Breast Cancer at the Society for Integrative Oncology 4Bionovo Presents Positive Results from Phase 1B Trial of BZL101 for Metastatic Breast Cancer at the Society for Integrative Oncology 5Radius Raises Additional $15 Million, Increasing Second Private Equity Financing Round to $82.5 Million 2PAREXEL Strengthens Leading Presence in Latin America With a New Location in Peru 2PAREXEL Strengthens Leading Presence in Latin America With a New Location in Peru 3PAREXEL Strengthens Leading Presence in Latin America With a New Location in Peru 4New Evidence That Brain-Plasticity Based Training has Broad Impact: Improved Cognition in Boomers, Improved Motor Control in Older Adults 2Breast cancer more aggressive among obese women 14374 1Breast cancer more aggressive among obese women 14374 2News from the March 2008 American Physical Society Meeting 3967 1News from the March 2008 American Physical Society Meeting 3967 2News from the March 2008 American Physical Society Meeting 3967 3News from the March 2008 American Physical Society Meeting 3967 4News from the March 2008 American Physical Society Meeting 3967 5Genmab and PDL BioPharma Close Sale of Antibody Manufacturing Facility 3963 1Genmab and PDL BioPharma Close Sale of Antibody Manufacturing Facility 3963 2Quaker 28R 29 Life 28R 29 Cereal Partners with Actress and Mom Holly Robinson Peete to Inspire Moms to Make Their Best Days Happen 14371 1Quaker 28R 29 Life 28R 29 Cereal Partners with Actress and Mom Holly Robinson Peete to Inspire Moms to Make Their Best Days Happen 14371 2Quaker 28R 29 Life 28R 29 Cereal Partners with Actress and Mom Holly Robinson Peete to Inspire Moms to Make Their Best Days Happen 14371 3
Colloidal Gold Conjugated, Streptavidin - 50 OD
Colloidal Gold Conjugated, Goat anti-rabbit IgG (H&L) - 50 OD
Colloidal Gold Conjugated, Goat anti-human IgG (H&L) - 50 OD
Colloidal Gold Conjugated, Protein A - 50 OD
Medicine Products: